Dr Reddys Laboratories (RDY) Share-based Compensation (2009)
Dr Reddys Laboratories (RDY) posted quarterly Share-based Compensation of $2.0 million for Q4 2009, up 100.0% quarter-over-quarter from $1.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Share-based Compensation (2009) Analysis & Trends
Dr Reddys Laboratories' Share-based Compensation history runs 1 years deep, the most recent figure standing at $2.0 million for Q4 2009.
- In Q4 2009, Share-based Compensation changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2009 stood at $5.5 million (changed N/A YoY), while the FY2026 annual figure was $3.0 million, down 40.0% from the prior year.
- Share-based Compensation for Q4 2009 stood at $2.0 million, up from $1.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $2.0 million in Q4 2009, with the low at $1.0 million in Q2 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 31.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 2.00 Mn |
| Dec 31, 2009 | 2.00 Mn |
| Sep 30, 2009 | 1.00 Mn |
| Sep 30, 2009 | 1.00 Mn |
| Jun 30, 2009 | 1.00 Mn |
| Jun 30, 2009 | 1.00 Mn |